New drug program aims to tame dangerous fat levels in blood

This program provides access to an investigational drug called plozasiran for people with severe, hard-to-control high triglycerides. It is for adults and adolescents (15+) with a rare genetic condition (FCS) and for adults with high-risk severe hypertriglyceridemia (SHTG) who have a history of pancreatitis. Participants receive injections every three months to try to lower their dangerously high blood fat levels and reduce the risk of serious complications like pancreatitis.